Literature DB >> 18426338

A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals.

Matthew Morrow1, Antonio Valentin, Richard Little, Robert Yarchoan, George N Pavlakis.   

Abstract

Peripheral blood CD27(+) B cells are reduced in HIV-1-infected individuals. In healthy individuals, the human peripheral blood CD27(+) B cell pool consists of two subsets defined by the expression, or lack thereof, of the CD45 isoform B220. We investigated the presence of circulating B220(+) and B220(-) memory B cells in HIV(+) individuals and found that the reduction in CD27(+) memory B cells occurs primarily among CD27(+)B220(-) B cells. Studies conducted using healthy controls indicate that CD27(+)B220(-) B cells have a splenic marginal zone like the immunophenotype IgM(hi)IgD(lo)CD21(+)CD23(-), express TLR9, and proliferate and secrete IgG and IgM in response to B cell-specific ODN. CD27(+)B220(+) B cells have the immunophenotype IgM(lo)IgD(hi)CD21(+)CD23(+), express activation-induced cytidine deaminase, and proliferate in response to SAC but do not secrete immunoglobulin. The AICD expression, along with CD86 expression, by CD27(+)B220(+) suggests these cells are of germinal center origin. The preferential depletion of CD27(+)B220(-) B cells mirrors alterations in spleen morphology and resident B cell populations due to HIV infection reported by other investigators and may play an important role in the defective B cell immunity against T-independent pathogens such as pneumococcus observed in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426338      PMCID: PMC2716037          DOI: 10.1089/aid.2007.0186

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  51 in total

1.  Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus.

Authors:  R S Klein; P A Selwyn; D Maude; C Pollard; K Freeman; G Schiffman
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

2.  CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

Authors:  Bing He; Xugang Qiao; Andrea Cerutti
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

3.  Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients.

Authors:  Yong Chong; Hideyuki Ikematsu; Masahiro Yamamoto; Masayuki Murata; Kouzaburo Yamaji; Mika Nishimura; Shigeki Nabeshima; Seizaburo Kashiwagi; Jun Hayashi
Journal:  AIDS Res Hum Retroviruses       Date:  2004-06       Impact factor: 2.205

4.  Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy.

Authors:  Nutthapong Tangsinmankong; Wasu Kamchaisatian; Noorbibi K Day; John W Sleasman; Patricia J Emmanuel
Journal:  Ann Allergy Asthma Immunol       Date:  2004-05       Impact factor: 6.347

5.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

Review 6.  B lymphocyte dysfunctions in HIV infection.

Authors:  Angelo De Milito
Journal:  Curr HIV Res       Date:  2004-01       Impact factor: 1.581

7.  Inhibition of normal B-cell function by human immunodeficiency virus envelope glycoprotein, gp120.

Authors:  N Chirmule; N Oyaizu; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

8.  Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.

Authors:  P Rieckmann; G Poli; C H Fox; J H Kehrl; A S Fauci
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patients.

Authors:  Yong Chong; Hideyuki Ikematsu; Kensuke Kikuchi; Masahiro Yamamoto; Masayuki Murata; Mika Nishimura; Shigeki Nabeshima; Seizaburo Kashiwagi; Jun Hayashi
Journal:  AIDS Res Hum Retroviruses       Date:  2004-02       Impact factor: 2.205

10.  Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Authors:  Susan Moir; Angela Malaspina; Oxana K Pickeral; Eileen T Donoghue; Joshua Vasquez; Natalie J Miller; Surekha R Krishnan; Marie A Planta; John F Turney; J Shawn Justement; Shyamasundaran Kottilil; Mark Dybul; JoAnn M Mican; Colin Kovacs; Tae-Wook Chun; Charles E Birse; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  17 in total

1.  Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

Authors:  Tatyana Vikulina; Xian Fan; Masayoshi Yamaguchi; Susanne Roser-Page; Majd Zayzafoon; David M Guidot; Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).

Authors:  Heather M Kling; Timothy W Shipley; Karen A Norris
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

Review 3.  HIV: inflammation and bone.

Authors:  Ighovwerha Ofotokun; Emily McIntosh; M Neale Weitzmann
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

4.  Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Sangita P Patil; Jan Kristoff; Marianne Bryan; Ronald C Montelaro; Alison Morris; Karen A Norris
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

5.  C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection.

Authors:  Catherine Hyams; Jerry C H Tam; Jeremy S Brown; Stephen B Gordon
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

6.  Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.

Authors:  Adriana Weinberg; Sharon Huang; Terence Fenton; Julie Patterson-Bartlett; Philimon Gona; Jennifer S Read; Wayne M Dankner; Sharon Nachman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

Review 7.  Antibody-secreting B cells in HIV infection.

Authors:  Nicole A Doria-Rose; Mark Connors
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

8.  Evidence of early B-cell dysregulation in simian immunodeficiency virus infection: rapid depletion of naïve and memory B-cell subsets with delayed reconstitution of the naïve B-cell population.

Authors:  David Kuhrt; Seth A Faith; Amanda Leone; Mukta Rohankedkar; Donald L Sodora; Louis J Picker; Kelly Stefano Cole
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

9.  B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.

Authors:  Peter Oballah; Britta Flach; Leigh A Eller; Michael A Eller; Benson Ouma; Mark de Souza; Hannah N Kibuuka; Fred Wabwire-Mangen; Bruce K Brown; Nelson L Michael; Merlin L Robb; David Montefiori; Victoria R Polonis
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

10.  Advances in human B cell phenotypic profiling.

Authors:  Denise A Kaminski; Chungwen Wei; Yu Qian; Alexander F Rosenberg; Ignacio Sanz
Journal:  Front Immunol       Date:  2012-10-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.